MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Stock Price, Quote & AI Analysis
Live MLTX stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for MoonLake Immunotherapeutics Class A Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
MoonLake Immunotherapeutics Class A Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
MoonLake Immunotherapeutics Class A Ordinary Shares Overview
Company information
Company Overview
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
MoonLake Immunotherapeutics Class A Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...